Organisations value Australia because it provides an affordable platform for R&D that does not compromise on the infrastructure needed for a quality research project. In terms of tax, Australia is amongst the most rewarding countries through its generous rebate program.
Indeed, companies conducting clinical research in the country receive 43.5% in tax credits. In comparison, the United States, another important research base, only provides a 6% rebate. Whatever the cost of the trial, the tax credit returns a significant portion to the organisation.